Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment
Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer Appointment   Aquestive Therapeutics, a pharmaceutical company specializing in advancing medicines to improve patients' lives, has recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for their product Libervant™ (diazepam) Buccal Film. The NDA is specifically for the..
